USANA Health Sciences (USNA) Tops Q2 EPS by 2c; Boosts FY11 Outlook
USANA Health Sciences (NASDAQ: USNA) reported Q2 EPS of $0.82, $0.02 better than the analyst estimate of $0.80. Revenue for the quarter came in at $148.9 million versus the consensus estimate of $147.33 million.
USANA Health Sciences sees FY2011 EPS of $3.05-$3.10, versus prior guidance of $2.85-$2.95 and the consensus of $3.10. USANA Health Sciences sees FY2011 revenue of $565-$575 million, versus prior guidance of $530-$550 million and the consensus of $583.57 million.
USANA Health Sciences sees FY2011 EPS of $3.05-$3.10, versus prior guidance of $2.85-$2.95 and the consensus of $3.10. USANA Health Sciences sees FY2011 revenue of $565-$575 million, versus prior guidance of $530-$550 million and the consensus of $583.57 million.